Imed Infinity Medical-Limited Partnership
Imed Infinity Medical-Limited Partnership, a research and development partnership, focuses on investing in research projects and development in the medical field, primarily the digital health field. Imed Infinity Medical-Limited Partnership was incorporated in 2020 and is based in Tel Aviv, Israel.
Imed Infinity Medical-Limited Partnership (IMED) - Net Assets
Latest net assets as of June 2025: ILA8.44 Million ILA
Based on the latest financial reports, Imed Infinity Medical-Limited Partnership (IMED) has net assets worth ILA8.44 Million ILA as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA8.60 Million) and total liabilities (ILA165.00K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA8.44 Million |
| % of Total Assets | 98.08% |
| Annual Growth Rate | -10.26% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 4.62 |
Imed Infinity Medical-Limited Partnership - Net Assets Trend (2020–2024)
This chart illustrates how Imed Infinity Medical-Limited Partnership's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Imed Infinity Medical-Limited Partnership (2020–2024)
The table below shows the annual net assets of Imed Infinity Medical-Limited Partnership from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ILA7.54 Million | -7.09% |
| 2023-12-31 | ILA8.11 Million | -17.91% |
| 2022-12-31 | ILA9.88 Million | -9.24% |
| 2021-12-31 | ILA10.89 Million | -6.28% |
| 2020-12-31 | ILA11.62 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Imed Infinity Medical-Limited Partnership's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 411700000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ILA11.65 Million | 154.60% |
| Other Comprehensive Income | ILA37.00K | 0.49% |
| Total Equity | ILA7.54 Million | 100.00% |
Imed Infinity Medical-Limited Partnership Competitors by Market Cap
The table below lists competitors of Imed Infinity Medical-Limited Partnership ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Simteract S.A.
WAR:SMT
|
$12.24K |
|
Lake Superior Acquisition Corp. Rights
NASDAQ:LKSPR
|
$12.25K |
|
XINYI GLASS HLDGS (XI9.SG)
STU:XI9
|
$12.26K |
|
Easson Holdings Ltd
PA:MLEAS
|
$12.26K |
|
Global Gaming Technologies Corp
PINK:BLKCF
|
$12.22K |
|
Genesis Healthcare Inc
PINK:GENN
|
$12.22K |
|
UR-ENERGY
MU:U9T
|
$12.21K |
|
Bebop Channel Corp
PINK:BBOP
|
$12.21K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Imed Infinity Medical-Limited Partnership's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 8,110,000 to 7,535,000, a change of -575,000 (-7.1%).
- Net loss of 575,000 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA-575.00K | -7.63% |
| Total Change | ILA- | -7.09% |
Book Value vs Market Value Analysis
This analysis compares Imed Infinity Medical-Limited Partnership's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 61.59x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 47.96x to 61.59x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | ILA2.36 | ILA113.00 | x |
| 2021-12-31 | ILA2.70 | ILA113.00 | x |
| 2022-12-31 | ILA2.46 | ILA113.00 | x |
| 2023-12-31 | ILA2.02 | ILA113.00 | x |
| 2024-12-31 | ILA1.83 | ILA113.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Imed Infinity Medical-Limited Partnership utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -7.63%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1402.44%
- • Asset Turnover: 0.01x
- • Equity Multiplier: 1.01x
- Recent ROE (-7.63%) is above the historical average (-9.57%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -1.17% | 0.00% | 0.00x | 1.01x | ILA-1.30 Million |
| 2021 | -7.04% | -1021.33% | 0.01x | 1.02x | ILA-1.85 Million |
| 2022 | -10.18% | -503.00% | 0.02x | 1.01x | ILA-1.99 Million |
| 2023 | -21.82% | 0.00% | -0.11x | 1.02x | ILA-2.58 Million |
| 2024 | -7.63% | -1402.44% | 0.01x | 1.01x | ILA-1.33 Million |
Industry Comparison
This section compares Imed Infinity Medical-Limited Partnership's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $22,641,000
- Average return on equity (ROE) among peers: -18.56%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Imed Infinity Medical-Limited Partnership (IMED) | ILA8.44 Million | -1.17% | 0.02x | $12.22K |
| Almeda Ventures Limited Partnership (AMDA) | $22.64 Million | -18.56% | 0.02x | $90.83K |